In a recent article in the journal, Barnes et al1 report that the BRIDGE trial2, which showed that perioperative bridging is ineffective in most patients with atrial fibrillation (AF), prompted a 14% absolute decrease in bridging in patients managed in 6 anticoagulation clinics in Michigan.